DIA is known for working closely with Industry and Regulators to enable in-depth discussion on relevant topics and exchange of ideas between different stakeholders.
Join the DIA Pharmacovigilance Strategy Workshop to get the latest insights from experts and learn about different aspects of pharmacovigilance through interactive sessions. Participation will help you broaden your knowledge and stimulate the exchange of ideas with other professionals.
The Workshop aims to stimulate dialogue and share practical experiences: it offers an opportunity to network, engage and share best practices as well as solution driven interactive round table sessions allowing you to engage with experts from different backgrounds.
DIA Pharmacovigilance Hackathon
Forming teams around a hot topic in pharmacovigilance and using a facilitated design-thinking framework to identify concrete next steps and possibly answers to these important questions. Each team will be pre-formed as a multi-stakeholder unit, in order to promote an impartial discussion. Participants will benefit from each other's different backgrounds as a strong driver for lateral thinking and creative problem-solving with some of the brightest minds in the life sciences field.
- The Future of Pharmacovigilance: What to Keep/Change?
More information on the registration to be divulged soon.
Want to learn more about Pharmacovigilance Strategies Workshop? You've come to the right site!
Short Course or Primer
To keep you at the forefront.
Bianca Mulder, PharmD, MPharm, MSc Pharmacovigilance Assessor
Medicines Evaluation Board, Netherlands
Maarten Lagendijk, MSc Deputy EU QPPV
James Whitehead, MBA, MSc Senior Director, Device & Digital Safety
AstraZeneca, United Kingdom
Francoise Sillan, MD EU1 UK QPPV
Wendy Huisman, PharmD Director
Shahin Kauser Leading Senior Scientific Assessor
MHRA, United Kingdom
Willemijn van der Spuij, MSc Executive Director, WorldWide Patient Safety International, Europe
Claudia Ferreira Scientific Programmes Specialist
Have an account?